GNE-617 hydrochloride is a potent and specific NAMPT inhibitor with an IC50 of 5 nM; it exhibits cytotoxic activity against non-small cell lung cancer (NSCLC) cell lines, with most cell lines showing IC50 values below 100 nM and approximately half below 10 nM; its cytotoxicity is largely reversible by nicotinic acid supplementation, indicating on-target NAMPT inhibition; it is used in preclinical studies to investigate NAMPT-dependent cancer cell viability and associated retinal toxicity.